Loading...
•
Dec 31, 2025
Concentra Group Holdings Q4 2025 Earnings Report
Concentra reported strong fourth quarter 2025 revenue and earnings growth with expanding Adjusted EBITDA and increased patient volumes.
Key Takeaways
Concentra delivered double-digit revenue and Adjusted EBITDA growth in Q4 2025, driven by higher patient visits, improved revenue per visit, and continued expansion of occupational health centers and onsite clinics.
Revenue increased 15.9% year-over-year to 539080000.
Net income rose 58.7% year-over-year to 36191000.
Adjusted EBITDA grew 22.9% year-over-year to 95269000 with margin expansion.
Patient visits per day increased 9.0% to 51005, with revenue per visit up 3.1% to 149.63.
Revenue by Segment
Forward Guidance
For full year 2026, Concentra expects revenue between 2250000000 and 2350000000, Adjusted EBITDA between 450000000 and 470000000, net leverage ratio of 3.0x or below, Free Cash Flow between 200000000 and 225000000, and capital expenditures between 70000000 and 80000000.
Positive Outlook
- Revenue guidance range of 2250000000 to 2350000000.
- Adjusted EBITDA expected between 450000000 and 470000000.
- Free Cash Flow projected between 200000000 and 225000000.
- Net leverage ratio targeted at 3.0x or below.
- Capital expenditures planned between 70000000 and 80000000 to support growth.
Challenges Ahead
- Guidance subject to macroeconomic and regulatory risks.
- Exposure to labor cost pressures.
- Dependence on reimbursement rate increases to offset inflation.
- Potential impact from changes in workers’ compensation regulations.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...